Physician profile
Jenna Thurman
NPI 1659766491
$1,278.57
in general payments reported to CMS, 2019-2025
15 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.69 · 2020: $110 · 2021: $111 · 2022: $228 · 2023: $300 · 2024: $287 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.77 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $252.44 | 2022-2025 | Azstarys |
| Pfizer INC. | $210.06 | 2022-2025 | |
| Tris Pharma INC | $172.20 | 2019-2023 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $159.33 | 2020-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Sanofi Pasteur INC. | $110.34 | 2020-2025 | |
| Glaxosmithkline, LLC. | $86.48 | 2020-2023 | Pediarix, Rotarix, Bexsero |
| Ironshore Pharmaceuticals INC. | $81.68 | 2021-2024 | |
| Neos Therapeutics, LP | $44.81 | 2020-2024 | Cotempla Xr-Odt |
| Collegium Pharmaceutical, INC. | $42.41 | 2025 | Jornay Pm |
| Sobi, INC | $29.22 | 2022-2023 | |
| Shire North American Group INC | $26.03 | 2019 | |
| Cranial Technologies, INC | $18.20 | 2024 | Doc Band |
| Kaleo, INC. | $16.90 | 2023 | Auvi-Q |
| Supernus Pharmaceuticals, INC. | $14.46 | 2023 | Qelbree |
| Adlon Therapeutics L.P. | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Thurman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.